Cortes et al. [10] showed that the alternative monoacylglycerol (MAG) pathway for TG synthesis was activated in the liver of AGPAT2-/- mice, leading to elevated TG levels in the liver, and, ultimately, hepatic steatosis. Here, AGPAT2 is linked to fatty liver disease.